Revlimid 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg hard capsules * Pharmacy Only: Prescription
Company:
Bristol-Myers Squibb Pharma EEIGStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Information for Patients
Risk Minimisation Materials
(Click to Download) Patient Information Pocket Card
Risk Minimisation Materials
(Click to Download) Adverse Event Report Form
Risk Minimisation Materials
(Click to Download) Combined Checklist for Commencing Treatment
Risk Minimisation Materials
(Click to Download) Community Pharmacy Dispensing Notification Form
Risk Minimisation Materials
(Click to Download) Healthcare Professional Information Guide
Risk Minimisation Materials
(Click to Download) Order Form
Risk Minimisation Materials
(Click to Download) Pharmacy Registration Form
Risk Minimisation Materials
(Click to Download) Pregnancy Report Form
Risk Minimisation Materials
(Click to Download) Pregnancy Outcome Form
Risk Minimisation Materials
(Click to Download) Prescription Authorisation Form
Risk Minimisation Materials
(Click to Download) Male Treatment Initiation Form
Risk Minimisation Materials
(Click to Download) Woman of Childbearing Potential Treatment Initiation Form
Risk Minimisation Materials
(Click to Download) Woman of Non-Childbearing Potential Treatment Initiation Form
Risk Minimisation Materials
(Click to Download) Additional Risk Minimisation Materials for Prescribers
Risk Minimisation Materials
(Click to Download) Additional Risk Minimisation Materials for Pharmacists
Risk Minimisation Materials